BillionToOne, Inc.
For the period ended Sep 30, 2025. Filed Dec 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Dec 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. EXHIBITS
(a) Exhibits
| Exhibit No | Description of Exhibit | Form | File No. | Exhibit Number | Filing Date | Filed or Furnished Herewith |
|---|---|---|---|---|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant | 8-K | 001-42934 | 3.1 | November 10, 2025 | |
| 3.2 | Amended and Restated Bylaws of Registrant | 8-K | 001-42934 | 3.2 | November 10, 2025 | |
| 10.1 | Amendment No. 1 to the Note Purchase Agreement, dated as September 4, 2025, by and among by and among the Registrant, the purchasers party thereto, and BWCB SA LLC (an entity affiliated with Oberland Capital Management, LLC), as purchaser’s agent. | S-1 | 333-290761 | 10.2 | October 07, 2025 | |
| 10.2 | Development and Commercialization Agreement with Janssen Biotech, Inc., dated July 11, 2025 | S-1/A | 333-290761 | 10.10 | October 17, 2025 | |
| 10.3 | Amendment No. 1 to Development and Commercialization Agreement with Janssen Biotech, Inc., dated October 15, 2025 | S-1/A | 333-290761 | 10.11 | October 17, 2025 | |
| 10.4+ | Form of Indemnification Agreement by and between the Registrant and each of its directors and executive officers | S-1 | 333-290761 | 10.11 | October 07, 2025 | |
| 10.5+ | 2025 Equity Incentive Plan | S-1/A | 333-290761 | 10.14 | October 17, 2025 | |
| 10.6+ | 2025 Employee Stock Purchase Plan | S-1/A | 333-290761 | 10.15 | October 17, 2025 | |
| 10.7+ | Executive Severance Plan | S-1/A | 333-290761 | 10.16 | October 17, 2025 | |
| 31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1* | Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X |
| 32.2* | Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104 | Cover Page formatted as Inline XBRL and contained in Exhibit 101 |
- Indicates a management contract or compensatory plan or arrangement.
† The Registrant has omitted portions of the exhibit (indicated by “[*]”) as permitted under Item 601(b)(10) of Regulation S-K because such information is both (i) not material and (ii) information that the Registrant treats as private or confidential. The Registrant hereby undertakes to furnish supplemental copies of the unredacted exhibit upon request by the SEC.
- The certifications furnished in Exhibits 32.1 and 32.2 are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.